Literature DB >> 3512443

Infection of gnotobiotic pigs with an Escherichia coli O157:H7 strain associated with an outbreak of hemorrhagic colitis.

D H Francis, J E Collins, J R Duimstra.   

Abstract

Gnotobiotic pigs inoculated with an Escherichia coli O157:H7 strain isolated from a human with hemorrhagic colitis developed anorexia, lethargy, and watery diarrhea. Bacteria diffusely colonized the cecum and colon surfaces and the crypt epithelium. At bacterial attachment sites, microvilli were effaced, and epithelial cells were irregularly shaped, rounded, or detached. Submucosa, lamina propria, and mesentery were markedly edematous and contained many inflammatory cells.

Entities:  

Mesh:

Year:  1986        PMID: 3512443      PMCID: PMC260992          DOI: 10.1128/iai.51.3.953-956.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Early pathogenesis of colitis in neonatal pigs monocontaminated with Escherichia coli. Fine structural changes in the colonic epithelium.

Authors:  T E Staley; L D Corley; E W Jones
Journal:  Am J Dig Dis       Date:  1970-10

2.  Modified thiocarbohydrazide procedure for scanning electron microscopy: routine use for normal, pathological, or experimental tissues.

Authors:  L E Malick; R B Wilson
Journal:  Stain Technol       Date:  1975-07

3.  A clinicopathologic study of enterocyte-adherent Escherichia coli: a cause of protracted diarrhea in infants.

Authors:  R Rothbaum; A J McAdams; R Giannella; J C Partin
Journal:  Gastroenterology       Date:  1982-08       Impact factor: 22.682

4.  Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7.

Authors:  R S Remis; K L MacDonald; L W Riley; N D Puhr; J G Wells; B R Davis; P A Blake; M L Cohen
Journal:  Ann Intern Med       Date:  1984-11       Impact factor: 25.391

5.  Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools.

Authors:  M A Karmali; B T Steele; M Petric; C Lim
Journal:  Lancet       Date:  1983-03-19       Impact factor: 79.321

6.  Enteropathogenic Escherichia coli enteritis: evaluation of the gnotobiotic piglet as a model of human infection.

Authors:  S Tzipori; R M Robins-Browne; G Gonis; J Hayes; M Withers; E McCartney
Journal:  Gut       Date:  1985-06       Impact factor: 23.059

7.  Rapid chemical dehydration of biologic samples for scanning electron microscopy using 2,2-dimethoxypropane.

Authors:  M D Maser; J J Trimble
Journal:  J Histochem Cytochem       Date:  1977-04       Impact factor: 2.479

8.  Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines.

Authors:  H W Moon; S C Whipp; R A Argenzio; M M Levine; R A Giannella
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

9.  Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype.

Authors:  J G Wells; B R Davis; I K Wachsmuth; L W Riley; R S Remis; R Sokolow; G K Morris
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

10.  Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli.

Authors:  A D O'Brien; G D LaVeck; M R Thompson; S B Formal
Journal:  J Infect Dis       Date:  1982-12       Impact factor: 5.226

View more
  60 in total

1.  Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication.

Authors:  Abhineet S Sheoran; Igor P Dmitriev; Elena A Kashentseva; Ocean Cohen; Jean Mukherjee; Michelle Debatis; Jonathan Shearer; Jacqueline M Tremblay; Gillian Beamer; David T Curiel; Charles B Shoemaker; Saul Tzipori
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

2.  Intestinal lesions associated with disseminated candidiasis in an experimental animal model.

Authors:  K A Andrutis; P J Riggle; C A Kumamoto; S Tzipori
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  Role of rpoS in acid resistance and fecal shedding of Escherichia coli O157:H7.

Authors:  S B Price; C M Cheng; C W Kaspar; J C Wright; F J DeGraves; T A Penfound; M P Castanie-Cornet; J W Foster
Journal:  Appl Environ Microbiol       Date:  2000-02       Impact factor: 4.792

Review 4.  Enteropathogenic Escherichia coli.

Authors:  M S Donnenberg; J B Kaper
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

5.  Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector.

Authors:  M S Donnenberg; J B Kaper
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

6.  Enterotoxigenic Escherichia coli modulates host intestinal cell membrane asymmetry and metabolic activity.

Authors:  Amber M Johnson; Radhey S Kaushik; Nicholas J Rotella; Philip R Hardwidge
Journal:  Infect Immun       Date:  2008-10-20       Impact factor: 3.441

Review 7.  Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.

Authors:  Saul Tzipori; Abhineet Sheoran; Donna Akiyoshi; Arthur Donohue-Rolfe; Howard Trachtman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Expression of mucin-type glycoprotein K88 receptors strongly correlates with piglet susceptibility to K88(+) enterotoxigenic Escherichia coli, but adhesion of this bacterium to brush borders does not.

Authors:  D H Francis; P A Grange; D H Zeman; D R Baker; R Sun; A K Erickson
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  The role of the eaeA gene in diarrhea and neurological complications in a gnotobiotic piglet model of enterohemorrhagic Escherichia coli infection.

Authors:  S Tzipori; F Gunzer; M S Donnenberg; L de Montigny; J B Kaper; A Donohue-Rolfe
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

10.  Enterohemorrhagic Escherichia coli O157:H7 requires intimin to colonize the gnotobiotic pig intestine and to adhere to HEp-2 cells.

Authors:  M L McKee; A R Melton-Celsa; R A Moxley; D H Francis; A D O'Brien
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.